• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Akums Drugs and Pharmaceuticals Limited — Updates, 13-11-2025: Press Release

    13-11-2025 | 05:35 pm

    Akums reported Q2 revenue of ₹1,018 Cr, EBITDA ₹94 Cr, and PAT ₹43 Cr. CDMO revenue was ₹804 Cr, with 7% volume growth. Significant global expansion includes a JV pharma plant in Zambia and initial commercial supply to Europe.

    No comments yet. Be the first to comment!

    All announcements from Akums Drugs and Pharmaceuticals Limited